Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • Weekly News
  • IR Room
  • RESEARCH
    • Semiconductors
  • Disclosures
    • Semiconductors
    • Energy
    • Bio & Healthcare
    • Defense
    • Shipbuilding
    • Automotive
  • Toggle search form
  • [Research] Samsung Electronics (005930) – IBK Securities | Memory ASP Surge · HBM4 Ramp-Up · Target Price Upgrade / 2026-07-08 RESEARCH
  • [Disclosure] Hanwha Aerospace (012450) – (Correction) Acquisition of Shares in Other Corporation / 2024-11-21 Disclosures
  • [Disclosure] Celltrion (068270) – (Correction) Investor Relations (IR) Presentation / 2024-11-27 Disclosures
  • [Disclosure] Hanwha Systems (272210) – Decision on Loan Guarantee for Others / 2024-11-29 Disclosures
  • [Disclosure] Samsung Electro-Mechanics (009150) – Closure of Shareholder Register or Record Date Setting / 2025-12-16 Semiconductors
  • [Disclosure] Jusung Engineering (036930) – Provisional Financial Results (Consolidated) / 2024-08-06 Semiconductors
  • [Disclosure] ALTEOGEN (196170) – Change of Market Division / 2025-04-30 Disclosures
  • [Disclosure] Celltrion (068270) – Decision on Cancellation of Shares / 2025-05-12 Disclosures

Category: Disclosures

[Disclosure] Celltrion (068270) – Application for Phase 3 Clinical Trial Plan for CT-P55 (Cosentyx Biosimilar) in the U.S. / 2024-07-01

Posted on July 1, 2024August 6, 2026 By K-STOCK Editor
[Disclosure] Celltrion (068270) – Application for Phase 3 Clinical Trial Plan for CT-P55 (Cosentyx Biosimilar) in the U.S. / 2024-07-01

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Celltrion announced that it has submitted an application for a global Phase 3 clinical trial plan to the U.S. Food and Drug Administration (FDA) to evaluate the efficacy and safety of CT-P55 compared with Cosentyx in patients with plaque psoriasis. 📊 [Key Disclosure Details & Financial…

Read More “[Disclosure] Celltrion (068270) – Application for Phase 3 Clinical Trial Plan for CT-P55 (Cosentyx Biosimilar) in the U.S. / 2024-07-01” »

Disclosures, Bio & Healthcare

[Disclosure] Celltrion (068270) – CHMP Positive Opinion Granted for CT-P43 (Stelara Biosimilar) by EMA / 2024-07-01

Posted on July 1, 2024August 6, 2026 By K-STOCK Editor
[Disclosure] Celltrion (068270) – CHMP Positive Opinion Granted for CT-P43 (Stelara Biosimilar) by EMA / 2024-07-01

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Celltrion announced that the Committee for Medicinal Products for Human Use (CHMP) under the European Medicines Agency (EMA) has issued a positive opinion recommending marketing authorization for CT-P43, a biosimilar to Stelara, across 30 European countries. 📊 [Key Disclosure Details & Financial Highlights] 📝 Editor’s Comment…

Read More “[Disclosure] Celltrion (068270) – CHMP Positive Opinion Granted for CT-P43 (Stelara Biosimilar) by EMA / 2024-07-01” »

Disclosures, Bio & Healthcare

[Disclosure] Hanwha Ocean (042660) – Sales and Supply Contract / 2024-07-01

Posted on July 1, 2024August 9, 2026 By K-STOCK Editor
[Disclosure] Hanwha Ocean (042660) – Sales and Supply Contract / 2024-07-01

Fact Source: Financial Supervisory Service DART / KOSCOM 💡 3-Second Summary This filing discloses Hanwha Ocean’s contract win valued at KRW 719.6B to construct four Very Large Crude Carriers (VLCC) for a Middle Eastern shipowner. 📊 [Key Disclosure Highlights & Summary] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Verification of Project Execution and Contract Amendments…

Read More “[Disclosure] Hanwha Ocean (042660) – Sales and Supply Contract / 2024-07-01” »

Disclosures, Shipbuilding

[Disclosure] Hanwha Ocean (042660) – Sales and Supply Contract / 2024-07-01

Posted on July 1, 2024August 9, 2026 By K-STOCK Editor
[Disclosure] Hanwha Ocean (042660) – Sales and Supply Contract / 2024-07-01

Fact Source: Financial Supervisory Service DART / KOSCOM 💡 3-Second Summary This filing discloses Hanwha Ocean’s contract win valued at KRW 1.4381T to construct four LNG carriers (LNGC) for a Middle Eastern shipowner. 📊 [Key Disclosure Highlights & Summary] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Verification of Project Execution and Contract Amendments This filing…

Read More “[Disclosure] Hanwha Ocean (042660) – Sales and Supply Contract / 2024-07-01” »

Disclosures, Shipbuilding

[Disclosure] Hanwha Ocean (042660) – Other Management Matters (Voluntary Disclosure) (Correction) / 2024-07-01

Posted on July 1, 2024August 9, 2026 By K-STOCK Editor
[Disclosure] Hanwha Ocean (042660) – Other Management Matters (Voluntary Disclosure) (Correction) / 2024-07-01

Fact Source: Financial Supervisory Service DART / KOSCOM 💡 3-Second Summary This filing discloses an amendment to Hanwha Ocean’s business acquisition plan, postponing the acquisition date of the wind power business to October 1, 2024, and executing an indemnity agreement with Hanwha Corporation for potential liquidated damages regarding the plant construction contract up to 10%…

Read More “[Disclosure] Hanwha Ocean (042660) – Other Management Matters (Voluntary Disclosure) (Correction) / 2024-07-01” »

Disclosures, Shipbuilding

[Disclosure] Samsung Electro-Mechanics (009150) – Matters Related to Sustainability Report (Voluntary Disclosure) / 2024-06-28

Posted on June 28, 2024July 30, 2026 By K-STOCK Editor
[Disclosure] Samsung Electro-Mechanics (009150) – Matters Related to Sustainability Report (Voluntary Disclosure) / 2024-06-28

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Samsung Electro-Mechanics voluntarily disclosed the publication of its ‘2023-2024 Samsung Electro-Mechanics Sustainability Report,’ prepared under GRI Standards 2021 and verified by the Korea Management Registrar (KMR). 📊 [Summary of Key Disclosure Facts & Figures] 1. Basic Report Information 2. Key Contents & Framework 3. Other Key…

Read More “[Disclosure] Samsung Electro-Mechanics (009150) – Matters Related to Sustainability Report (Voluntary Disclosure) / 2024-06-28” »

Semiconductors, Disclosures

[Disclosure] SK Square(402340) – Matters Related to Sustainability Report / 2024-06-28

Posted on June 28, 2024July 31, 2026 By K-STOCK Editor
[Disclosure] SK Square(402340) – Matters Related to Sustainability Report / 2024-06-28

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary SK Square has officially released its sustainability report titled ‘2023 SK Square ESG Report’, detailing its financial and non-financial ESG performance for 2023. 📊 [Key Disclosure Details & Financial Summary] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Verification of Sustainability Report Publication and Official Data This…

Read More “[Disclosure] SK Square(402340) – Matters Related to Sustainability Report / 2024-06-28” »

Semiconductors, Disclosures

[Disclosure] Hyundai Motor (005380) – Publication of Sustainability Report and Related Matters / 2024-06-28

Posted on June 28, 2024August 12, 2026 By K-STOCK Editor
[Disclosure] Hyundai Motor (005380) – Publication of Sustainability Report and Related Matters / 2024-06-28

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Hyundai Motor announced the publication of the ‘2024 Hyundai Motor Sustainability Report,’ detailing its non-financial performance and management activities. 📊 [Key Disclosure Contents & Major Figures Summary] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Verification of Key ESG Performance Metrics via the Sustainability Report This disclosure…

Read More “[Disclosure] Hyundai Motor (005380) – Publication of Sustainability Report and Related Matters / 2024-06-28” »

Disclosures, Automotive

[Disclosure] Samsung Biologics (207940) – Other Market Information (Industry Reclassification) / 2024-06-28

Posted on June 28, 2024August 7, 2026 By K-STOCK Editor
[Disclosure] Samsung Biologics (207940) – Other Market Information (Industry Reclassification) / 2024-06-28

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary This notice from the Korea Exchange announces that Samsung Biologics’ sub-class industry designation has been revised to ‘Manufacture of Basic Pharmaceutical Products’ due to amendments in standard classification regulations. 📊 [Key Disclosure Details & Summary Statistics] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Verifying Reclassification Updates…

Read More “[Disclosure] Samsung Biologics (207940) – Other Market Information (Industry Reclassification) / 2024-06-28” »

Disclosures, Bio & Healthcare

[Disclosure] Celltrion (068270) – Other Market Notice (Industry Reclassification) / 2024-06-28

Posted on June 28, 2024August 6, 2026 By K-STOCK Editor
[Disclosure] Celltrion (068270) – Other Market Notice (Industry Reclassification) / 2024-06-28

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Following revisions to Statistics Korea’s Korean Standard Industrial Classification (KSIC) and KRX KOSPI market regulations, Celltrion’s sub-industry classification will be changed from “Manufacture of basic pharmaceutical products and biological preparations” to “Manufacture of basic pharmaceutical products” effective July 1, 2024. 📊 [Key Disclosure Details & Financial…

Read More “[Disclosure] Celltrion (068270) – Other Market Notice (Industry Reclassification) / 2024-06-28” »

Disclosures, Bio & Healthcare

Posts pagination

Previous 1 … 209 210 211 … 252 Next
  • [Research] Samsung Electro-Mechanics (009150) – Mirae Asset Securities | On-Device AI MLCC Surge · AI Power MLCC · P/B Valuation Floor / 2024-10-08 RESEARCH
  • [Research] Samsung Electro-Mechanics (009150) – iM Securities | Automotive & Server Mix · Expanding MLCC Share · FC-BGA Upgrades / 2025-07-01 Uncategorized
  • [Disclosure] SK square(402340) – New Facility Investment / 2026-02-25 Semiconductors
  • [Disclosure] Celltrion (068270) – Submission of Application for Phase 3 Clinical Trial Plan for CT-P44 (Darzalex Biosimilar) in Europe (Part 1) / 2024-11-28 Disclosures
  • [Disclosure] Hanwha Ocean (042660) – (Correction) Sales and Supply Contract / 2026-02-20 Disclosures
  • [Disclosure] Hanwha Ocean (042660) – Advance Notice of Earnings Release / 2025-10-13 Disclosures
  • [Disclosure] Jusung Engineering(036930) – Decision on Stock Cancellation / 2024-07-04 Semiconductors
  • [Disclosure] ALTEOGEN (196170) – Results of General Shareholders Meeting / 2025-03-31 Disclosures

Copyright © 2026 K-Stock Briefing.

Powered by PressBook News Dark theme